Bausch Health Companies Inc. (BHC)
NYSE: BHC · IEX Real-Time Price · USD
10.61
+0.12 (1.14%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Bausch Health Companies Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for BHC stock have an average target of 12.5, with a low estimate of 9.00 and a high estimate of 16. The average target predicts an increase of 17.81% from the current stock price of 10.61.
Analyst Consensus: Buy
* Price targets were last updated on Feb 23, 2024.
Analyst Ratings
The average analyst rating for BHC stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | -15.17% | Feb 23, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades $9 → $16 | Hold → Strong Buy | Upgrades | $9 → $16 | +50.80% | Sep 20, 2023 |
TD Cowen | TD Cowen | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 16, 2023 |
Jefferies | Jefferies | Strong Buy Maintains $7 → $9.5 | Strong Buy | Maintains | $7 → $9.5 | -10.46% | May 22, 2023 |
RBC Capital | RBC Capital | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | -24.60% | May 5, 2023 |
Financial Forecast
Revenue This Year
9.50B
from 8.76B
Increased by 8.48%
Revenue Next Year
9.76B
from 9.50B
Increased by 2.77%
EPS This Year
3.96
from -1.62
EPS Next Year
4.46
from 3.96
Increased by 12.67%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.9B | 10.2B | 10.5B | 10.3B | 9.5B |
Avg | 9.5B | 9.8B | 9.9B | 9.6B | 9.0B |
Low | 9.2B | 9.4B | 9.3B | 9.1B | 8.6B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 13.2% | 7.7% | 7.8% | 4.0% | -1.4% |
Avg | 8.5% | 2.8% | 1.2% | -2.6% | -6.7% |
Low | 4.8% | -0.8% | -5.1% | -8.0% | -11.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.39 | 5.27 | 5.53 | 5.15 | 4.10 |
Avg | 3.96 | 4.46 | 4.40 | 4.95 | 3.94 |
Low | 3.60 | 3.85 | 3.37 | 4.80 | 3.82 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 33.1% | 24.0% | 17.0% | -17.3% |
Avg | - | 12.7% | -1.4% | 12.5% | -20.4% |
Low | - | -2.7% | -24.4% | 9.2% | -22.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.